AVIVA STRATEGIES (FKA MGB CONSULTING)
AVIVA STRATEGIES (FKA MGB CONSULTING) is named as the registrant in 7 lobbying reports we hold for 2026-Q2, for 7 clients. 0 reports of 7 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| ACT FOR ULTRA RARE | 2026-Q2: $37,500 in income | 1 |
| ARPA-H GO | 2026-Q2: $12,500 in income | 1 |
| BEAM THERAPEUTICS | 2026-Q2: No amount stated | 1 |
| ELEMENT BIOSCIENCES | 2026-Q2: $44,000 in income | 1 |
| ENDEAVOR BIOMEDICINES | 2026-Q2: $51,000 in income | 1 |
| HUNTINGTON'S DISEASE SOCIETY OF AMERICA | 2026-Q2: $7,500 in income | 1 |
| TAYSHA GENE THERAPIES | 2026-Q2: $20,000 in income | 1 |
Lobbyists named in these reports
- MAX GABRIEL BRONSTEIN · 4 reports
Bills named, and how the House and the Senate voted
1 bill named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 7953FAIR ACT | Introduced | No recorded vote in our record |
Issues named: Health Issues (4), Medical/Disease Research/Clinical Labs (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| ARPA-H GOHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ACT FOR ULTRA RAREHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| HUNTINGTON'S DISEASE SOCIETY OF AMERICA | 2nd Quarter - Termination (No Activity) | The report on LDA.gov | |
| TAYSHA GENE THERAPIES | 2nd Quarter - Report (No Activity) | The report on LDA.gov | |
| BEAM THERAPEUTICS | 2nd Quarter - Termination (No Activity) | The report on LDA.gov | |
| ENDEAVOR BIOMEDICINESHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ELEMENT BIOSCIENCESHealth Issues, Medical/Disease Research/Clinical Labs | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.